References
- ABarbato, TFrischer, CEKuehni, DSnijders, IAzevedo, GBaktai, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J 2009;34:1264–76.
- JKMarthin, NPetersen, LTSkovgaard, KGNielsen. Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study. Am J Respir Crit Care Med 2010;181:1262–8.
- PGNoone, MWLeigh, ASannuti, SLMinnix, JLCarson, MHazucha, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004;169:459–67.
- WJFokkens, VJLund, JMullol, CBachert, IAlobid, FBaroody, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 2012;50:3–298.
- RLGibson, JLBurns, BWRamsey. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918–51.
- HKJohansen, KAanaes, TPressler, KGNielsen, JFisker, MSkov, et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros 2012;11:525–31.
- LJelsbak, HKJohansen, ALFrost, RThogersen, LEThomsen, OCiofu, et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 2007;75:2214–24.
- HJBonestroo, KMde Winter-de Groot, CKvan der Ent, HGArets. Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways. J Cyst Fibros 2010;9:130–4.
- MMaglione, ABush, KGNielsen, CHogg, SMontella, JKMarthin, et al. Multicenter analysis of body mass index, lung function, and sputum microbiology in primary ciliary dyskinesia. Pediatr Pulmonol 2014; Epub ahead of print.
- MCPasteur, DBilton, ATHill. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010;65:i1–58.
- NKapur, KGrimwood, IBMasters, PSMorris, ABChang. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol 2012;47:300–7.
- MProesmans, WBalinska-Miskiewicz, LDupont, XBossuyt, JVerhaegen, NHøiby, et al. Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006;27:937–43.
- KAanaes, HKJohansen, MSkov, FFBuchvald, THjuler, TPressler, et al. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients – can chronic lung infections be postponed? Rhinology 2013;51:222–30.
- BOjeniyi, BFrederiksen, NHøiby. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr Pulmonol 2000;29:177–81.
- TPressler, FKarpati, MGranstrom, PKKnudsen, ALindblad, LHjelte, et al. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros 2009;8:37–42.
- NHøiby, EWFlensborg, BBeck, BFriis, SVJacobsen, LJacobsen. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis 1977;58:65–79.
- RCBoucher. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004;23:146–58.
- DSParsons, BAGreene. A treatment for primary ciliary dyskinesia: efficacy of functional endoscopic sinus surgery. Laryngoscope 1993;103:1269–72.
- TPressler, BFrederiksen, MSkov, PGarred, CKoch, NHøiby. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection – a case control study. J Cyst Fibros 2006;5:9–15.
- KAanaes, Cvon Buchwald, THjuler, MSkov, MAlanin, HKJohansen. The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis. Am J Rhinol Allergy 2013;27:e1–4.